Example: Heart Attack

Search clinical trials for: Isotrifolin

Total 12 results

NCT04474626

Withdrawn

Isoquercetin in Sickle Cell Anemia

Conditions: Sickle Cell Disease; Sickle Cell-Beta0-Thalassemia
NCT04536090

Not yet recruiting

Study of Isoquercetin (IQC-950AN) Plus Standard of Care Versus Standard of Care Only for the Treatment of COVID-19

Conditions: COVID-19
NCT02195232

Active, not recruiting

Cancer Associated Thrombosis and Isoquercetin (CATIQ)

Conditions: Thromboembolism of Vein VTE in Colorectal Cancer; Thromboembolism of Vein in Pancreatic Cancer; Thromboembolism of Vein in Non-small Cell Lung Cancer
NCT04622865

Recruiting

Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19

Conditions: SARS-CoV 2; COVID-19; Coronavirus Disease 2019
NCT01722669

Completed

Quercetin PK/PD Study in Healthy Adults and Patients With Hypercoagulable States

Conditions: Healthy
NCT02446795

Unknown status

Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-line Sunitinib: a Phase I/II Trial

Conditions: Renal Cell Carcinoma; Kidney Cancer
NCT04514510

Recruiting

Fixed Dose Flavonoid Isoquercetin on Thrombo-Inflammatory Biomarkers in Subjects With Stable Sickle Cell Disease

Conditions: Sickle Cell Disease
NCT02866448

Withdrawn

Impact of isoQUercetin and Aspirin on Platelet Function

Conditions: Cardiovascular Disease
NCT02552888

Completed

Nitrite, Isoquercetin and Endothelial Dysfunction (NICE) Trial

Conditions: Chronic Kidney Disease
NCT02818699

Completed

Body Fat Reducing Effect and Safety of Enzymatically Modified Isoquercitrin in Overweight and Obese Subjects

Conditions: Overweight; Obese
NCT00913081

Completed

Advancing Niacin by Inhibiting Flushing (ANTI-FLUSH)

Conditions: Flushing
NCT01691404

Completed

Study on the Effects of Epicatechin and Quercetin Supplementation on Vascular Function and Blood Pressure (FLAVO)

Conditions: Hypertension; Endothelial Dysfunction